CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 2,762	$ 1,877
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,651	1,500
Deferred income taxes and investment tax credits	234	387
Equity earnings	(1,086)	(1,118)
Foreign currency transaction (gains) losses, net	(1)	18
Share-based compensation expense	53	49
Fixed-price contracts and other derivatives	(580)	200
Bad debt expense	368	110
Other	7	47
Reserve for Aliso Canyon costs	(3)	(1,835)
Net change in other working capital components	1,613	(267)
Insurance receivable for Aliso Canyon costs	0	350
Distributions from investments	668	643
Changes in other noncurrent assets and liabilities, net	(557)	(506)
Net cash provided by operating activities	5,129	1,455
CASH FLOWS FROM INVESTING ACTIVITIES
Expenditures for property, plant and equipment	(6,074)	(3,540)
Expenditures for investments	(281)	(275)
Purchases of nuclear decommissioning and other trust assets	(462)	(530)
Proceeds from sales of nuclear decommissioning and other trust assets	503	530
Repayments of advances to unconsolidated affiliates	0	626
Other	10	6
Net cash used in investing activities	(6,304)	(3,183)
CASH FLOWS FROM FINANCING ACTIVITIES
Common dividends paid	(1,109)	(1,070)
Preferred dividends paid	(22)	(22)
Issuances of common stock	0	4
Repurchases of common stock	(32)	(478)
Issuances of debt (maturities greater than 90 days)	6,911	6,711
Payments on debt (maturities greater than 90 days) and finance leases	(6,018)	(3,365)
Increase (decrease) in short-term debt, net	629	(1,438)
Advances from unconsolidated affiliates	31	28
Proceeds from sales of noncontrolling interests	1,238	1,732
Distributions to noncontrolling interests	(289)	(146)
Contributions from noncontrolling interests	1,036	15
Settlement of cross-currency swaps	(99)	0
Other	(78)	(35)
Net cash provided by financing activities	2,198	1,936
Effect of exchange rate changes on cash, cash equivalents and restricted cash	6	(3)
Increase in cash, cash equivalents and restricted cash	1,029	205
Cash, cash equivalents and restricted cash, January 1	462	581
Cash, cash equivalents and restricted cash, September 30	1,491	786
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest payments, net of amounts capitalized	836	732
Income tax payments, net of refunds	162	241
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Repayment of advances from unconsolidated affiliate in lieu of distribution	36	32
Accrued capital expenditures	1,200	738
Increase in finance lease obligations for investment in PP&E	47	33
(Decrease) increase in ARO for investment in PP&E	(15)	49
Contributions from NCI	200	0
Sale of NCI post-closing adjustment payable	11	0
Preferred stock
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Dividends declared but not paid	22	22
Common stock
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Dividends declared but not paid	$ 374	$ 360